Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05291975 · ClinicalTrials.gov registry record · NA
Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain
A NA study, sponsored by Erchonia Corporation.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT05291975 is a NA study that has completed, run by Erchonia Corporation. The registered enrollment target is 64 participants.
The verdict
NCT05291975, a NA study, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia® EVRL™, manufactured by Erchonia Corporation (the Company), in providing prescription home use application for temporary relief of diabetic neuropathy foot pain in individuals diagnosed with diabetic neuropathy by a suitably qualified and licensed health professional.
Interventions
- DEVICE Placebo Laser
- DEVICE Erchonia® EVRL™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2022-02-17 |
| Est. Completion | 2024-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05291975
The ClinicalTrials.gov registry entry for NCT05291975 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Laser is the first listed.
NCT05291975 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05291975 about?
NCT05291975 is a clinical study titled "Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain". The purpose of this clinical study is to determine the effectiveness of the Erchonia® EVRL™, manufactured by Erchonia Corporation (the Company), in providing prescription home use application for temporary relief of diabetic neuropathy foot pain in individuals diagnosed with diabetic neuropathy by a...
What is the current status of trial NCT05291975?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2022-02-17. Estimated completion is 2024-12-12.
What interventions are being tested in trial NCT05291975?
The interventions under investigation include: Placebo Laser (DEVICE), Erchonia® EVRL™ (DEVICE).
Who is sponsoring clinical trial NCT05291975?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.